The Physician Engagement Education Series brings healthcare providers together from around the world to discuss and share ideas on current and cutting edge concepts in medicine through interactive broadcasts. The interactive format includes case presentations and discussion by key opinion leaders from around the world with audience and faculty interaction, discussion, polling and debate. The live broadcasts are recorded and available online for healthcare providers to review even after the live event.
This activity has been approved for AMA PRA Category 1 Credit™.
Ajay Gupta, M.D. is the head of the section of Pediatric Epilepsy in the Epilepsy Center/Neurological Institute. He is Associate Professor at The Cleveland Clinic Lerner College of Medicine, Case Western Reserve University. He is also the founder director of multidisciplinary Tuberous Sclerosis Program at the Cleveland Clinic.
Imad Michel Najm, MD, is Director of Cleveland Clinic's Epilepsy Center at the Cleveland Clinic Neurological Institute. Dr Najm received his Medical Doctor degree from Saint Joseph University in Beirut, Lebanon in 1988. After one year of internship in Paris, France, Dr Najm became a Post-Doctoral Research Fellow in the Department of Neurobiology at the University of Southern California from 1989 till 1992. During that period, Dr Najm's research focused on the basic mechanisms of status epilepticus induced neuronal injury.
Dr. Elaine Wyllie, Professor of Pediatrics, is a world renowned thought leader in epilepsy medicine. Dr. Wyllie has been on the Castle Connolly list of America’s Best Doctors for many years, as well as on several other national and regional Top Doctors lists. Her many honors and awards include the highly competitive Award for Outstanding Work in Epilepsy Research from the Milken Family Foundation and the American Epilepsy Society and Honorary Membership in the Canadian Association for Child Neurology.
• Create opportunities for successful re-operation after incomplete transsective hemispherectomy
• Identify patients with treatable forms of autoimmune epilepsy
• Reduce the incidence of long term morbidity from refractory status epilepticus
• Improve management of epilepsy in women of childbearing age
• Expand surgical options for patients with complicated refractory focal epilepsy, through informed use of advanced invasive monitoring techniques
• Identify candidates for early epilepsy surgery to minimize lifetime seizure burden and health care utilization
• Recognize opportunities to reduce morbidity from adverse effects and seziures by exploring new antiepileptic medications when appropriate • Prevent suicide in teens and adults who are experiencing epilepsy and prevention